Sami Labs Exhibits Its Potential At CPhi Mumbai

SAMI Labs exhibits its business expansion plans of new manufacturing unit in Hyderabad at CPhi Event 2014.

Bengaluru, Karnataka, December 2, 2014 /India PRwire/ -- Bangalore based Indian Multinational Health Science Company, Sami Labs Ltd which manufactures and markets Phytonutrients and standardized herbal extracts, specialty fine chemicals, and organic intermediates used in the nutritional, pharmaceutical and food industries, today announced that it is exhibiting and participating at the CPhI India event to be held in Mumbai from 2nd to 4th December, 2014 at Booth U10 in Hall 2.

CPhI India, which is into its 8th year of existence, is one of the biggest and most comprehensive pharmaceutical industry events in South Asia.

Sami Labs, which recently announced the acquisition of a second ultra-modern Biotech manufacturing facility in Hyderabad and with an overall seven manufacturing units across the globe, will feature the following products at the CPhI event:

Custom Formulations - Cosmeceuticals and Nutraceuticals

C3 Reduct, the next generation Curcumin

Speciality Fine Chemicals

Nutritional Fine Chemicals

Sports Nutrition Ingredients

Standardized Herbal Extracts for the Nutraceutical division of Pharma Companies

Under the leadership of the Founder and Managing Director, Dr. Muhammed Majeed, over the past two and a half decades, the Sami-Sabinsa group has grown into a health science

multinational organization with presence in USA, Europe, Japan, Australia, China, UAE, South Africa, Vietnam and Malaysia.

"The CPhI India event is a perfect opportunity for us to meet new and existing business partners, customers, industry stakeholders and influencers in order to showcase our latest and most innovative products and solutions to the world. At the same time, the platform also allows us to enhance our understanding on the current state of the healthcare market," said Dr. Muhammed Majeed, Founder and Managing Director, Sami Labs Ltd.

Notes to Editor

About Sami Labs Ltd.

"The vision of a research scientist and a passionate entrepreneur takes on social and commercial expressions." This, in short, explains the genesis and growth of Sami Labs"

Dr. Muhammed Majeed established Sabinsa Corporation during the year 1988 in the state of New Jersey, USA with the objective of importing and marketing generic drugs into the US for the drug molecules coming off patent. Very soon he introduced into the US market a new line of products based on Indian herbal plants. It was Dr. Majeed who introduced to the Americans that Ayurveda from India can act as a complete curative to their various ailments. The persistent efforts made by Dr. Majeed in the early nineties in the field of Ayurveda did reap benefits among the Americans. To facilitate the increased demand for innovative application- based products, Sami Labs Limited (formerly known as Sami Chemicals & Extracts Limited) was set up in 1991 in Bangalore as a research and development facility. Today the main thrust and focus of Sami is on new product development and market oriented research. To cater to the expanding global market, Sami Labs has fully owned subsidiaries in USA, Europe, Japan, Australia, Malaysia, Philippines, Vietnam, UAE, China, Russia and South Korea.

For further information please contact: media@samilabs.com


Journalists and Bloggers
Visit India PRwire for Journalists for releases, photos, email alerts and customized feeds just for Media.

If you have any query regarding information in the press releases, please contact the company listed in the press release itself. Please do not call India PRwire, we will be unable to assist you with your inquiry.


SAMI Direct recent press release(s)


Sami Direct partners with Beauty and Aesthetics Society of Nagaland (BASN), recognizes & congratulates Miss Nagaland Beauty Pageant Winners 2014

SAMI Direct, India's fastest growing direct selling company promoted its personal care products under brand name 'Johara' aiming at the inner beauty of women as well as women's health.